Cidara Therapeutics
(NASDAQ) CDTX
This security has been delisted. This page is retained for historical reference.
CDTX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowCDTX Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
-37.30%
Return on Capital
-105.52%
Return on Assets
-25.53%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
-$141.29M
Operating Income
-$195.46M
EBITDA
-$184.64M
Operating Cash Flow
-$132.94M
Capital Expenditure
$0.00
Free Cash Flow
-$132.94M
Cash & ST Invst.
$293.65M
Total Debt
$1.98M
Cidara Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$45.00M
-262.1%
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
38
N/A
Net Income
-$83.23M
-420.7%
EBITDA
-$83.21M
-437.7%
Quarterly Fundamentals
Total Cash
$293.65M
+130.5%
Total Debt
$1.98M
-49.7%
Accounts Receivable
$1.86M
+9.5%
Inventory
$0.00
N/A
Long Term Debt
$424.00K
-82.0%
Short Term Debt
$1.56M
-1.3%
Return on Assets
-25.53%
N/A
Return on Invested Capital
-33.41%
N/A
Free Cash Flow
-$40.62M
-10.4%
Operating Cash Flow
-$40.62M
-10.7%